NCT07855185

Brief Summary

The aim of this study is to investigate the relationship between trapezius muscle oxygenation and cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
3mo left

Started Oct 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

October 5, 2026

Expected
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2026

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2027

Last Updated

October 2, 2026

Status Verified

September 1, 2026

Enrollment Period

1 month

First QC Date

September 28, 2026

Last Update Submit

September 28, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Trapezius Muscle Oxygen Saturation

    Trapezius muscle oxygen saturation will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.

    First Day

  • Trapezius Total Hemoglobin

    Trapezius total hemoglobin will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.

    First day

Secondary Outcomes (4)

  • Trapezius Muscle Strength

    Second Day

  • Cervical Range of Motion

    Second day

  • Neck Disability

    Second day

  • Upper-Extremity Exercise Capacity

    First Day

Study Arms (1)

Chronic Neck Pain Group

Adults aged 18-65 years with chronic neck pain lasting at least 12 weeks will be included in the study.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18-65 years with chronic neck pain lasting for at least 12 weeks who meet the study eligibility criteria.

You may qualify if:

  • Aged 18-65 years.
  • Chronic neck pain lasting for at least 3 months.
  • Neck pain intensity of ≥3 on the Visual Analog Scale during activity.
  • Willingness to participate in the study.

You may not qualify if:

  • Motor deficit in the upper extremities.
  • History of cervical or upper-extremity surgery.
  • Rheumatologic or neurologic disease.
  • Any musculoskeletal condition affecting upper-extremity function.
  • Cervical injection or other invasive procedure within the previous 6 months.
  • Cognitive impairment preventing understanding or performance of study assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırşehir Ahi Evran University.

Kırşehir, 40100, Turkey (Türkiye)

Location

Central Study Contacts

Başak Kavalcı Kol, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

September 28, 2026

First Posted

October 2, 2026

Study Start (Estimated)

October 5, 2026

Primary Completion (Estimated)

November 5, 2026

Study Completion (Estimated)

January 5, 2027

Last Updated

October 2, 2026

Record last verified: 2026-09

Locations